Literature DB >> 22230587

Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5.

Kazuyuki Tanabe1, Nobuko Arisue, Nirianne M Q Palacpac, Masanori Yagi, Takahiro Tougan, Hajime Honma, Marcelo U Ferreira, Anna Färnert, Anders Björkman, Akira Kaneko, Masatoshi Nakamura, Kenji Hirayama, Toshihiro Mita, Toshihiro Horii.   

Abstract

SERA5 is regarded as a promising malaria vaccine candidate of the most virulent human malaria parasite Plasmodium falciparum. SERA5 is a 120 kDa abundantly expressed blood-stage protein containing a papain-like protease. Since substantial polymorphism in blood-stage vaccine candidates may potentially limit their efficacy, it is imperative to fully investigate polymorphism of the SERA5 gene (sera5). In this study, we performed evolutionary and population genetic analysis of sera5. The level of inter-species divergence (kS=0.076) between P. falciparum and Plasmodium reichenowi, a closely related chimpanzee malaria parasite is comparable to that of housekeeping protein genes. A signature of purifying selection was detected in the proenzyme and enzyme domains. Analysis of 445 near full-length P. falciparum sera5 sequences from nine countries in Africa, Southeast Asia, Oceania and South America revealed extensive variations in the number of octamer repeat (OR) and serine repeat (SR) regions as well as substantial level of single nucleotide polymorphism (SNP) in non-repeat regions (2562 bp). Remarkably, a 14 amino acid sequence of SERA5 (amino acids 59-72) that is known to be the in vitro target of parasite growth inhibitory antibodies was found to be perfectly conserved in all 445 worldwide isolates of P. falciparum evaluated. Unlike other major vaccine target antigen genes such as merozoite surface protein-1, apical membrane antigen-1 or circumsporozoite protein, no strong evidence for positive selection was detected for SNPs in the non-repeat regions of sera5. A biased geographical distribution was observed in SNPs as well as in the haplotypes of the sera5 OR and SR regions. In Africa, OR- and SR-haplotypes with low frequency (<5%) and SNPs with minor allele frequency (<5%) were abundant and were mostly continent-specific. Consistently, significant genetic differentiation, assessed by the Wright's fixation index (Fst) of inter-population variance in allele frequencies, was detected for SNPs and both OR- and SR-haplotypes among almost all parasite populations. The exception was parasite populations between Tanzania and Ghana, suggesting frequent gene flow in Africa. The present study points to the importance of investigating whether biased geographical distribution for SNPs and repeat variants in the OR and SR regions affect the reactivity of human serum antibodies to variants.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22230587     DOI: 10.1016/j.vaccine.2011.12.124

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Epidemiology of malaria in a village in the Rufiji River Delta, Tanzania: declining transmission over 25 years revealed by different parasitological metrics.

Authors:  Anna Färnert; Victor Yman; Manijeh Vafa Homann; Grace Wandell; Leah Mhoja; Marita Johansson; Salome Jesaja; Johanna Sandlund; Kazuyuki Tanabe; Ulf Hammar; Matteo Bottai; Zulfiqarali G Premji; Anders Björkman; Ingegerd Rooth
Journal:  Malar J       Date:  2014-11-26       Impact factor: 2.979

Review 2.  Strategies for designing and monitoring malaria vaccines targeting diverse antigens.

Authors:  Alyssa E Barry; Alicia Arnott
Journal:  Front Immunol       Date:  2014-07-28       Impact factor: 7.561

3.  Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda.

Authors:  Masanori Yagi; Nirianne M Q Palacpac; Kazuya Ito; Yuko Oishi; Sawako Itagaki; Betty Balikagala; Edward H Ntege; Adoke Yeka; Bernard N Kanoi; Osbert Katuro; Hiroki Shirai; Wakaba Fukushima; Yoshio Hirota; Thomas G Egwang; Toshihiro Horii
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.

Authors:  Nyamongo Onkoba; Ruth M Mumo; Horace Ochanda; Charles Omwandho; Hastings S Ozwara; Thomas G Egwang
Journal:  J Biomed Res       Date:  2017-07-13

5.  Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5.

Authors:  Takahiro Tougan; Jyotheeswara R Edula; Eizo Takashima; Masayuki Morita; Miki Shinohara; Akira Shinohara; Takafumi Tsuboi; Toshihiro Horii
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

6.  Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

Authors:  Nirianne Marie Q Palacpac; Edward Ntege; Adoke Yeka; Betty Balikagala; Nahoko Suzuki; Hiroki Shirai; Masanori Yagi; Kazuya Ito; Wakaba Fukushima; Yoshio Hirota; Christopher Nsereko; Takuya Okada; Bernard N Kanoi; Kohhei Tetsutani; Nobuko Arisue; Sawako Itagaki; Takahiro Tougan; Ken J Ishii; Shigeharu Ueda; Thomas G Egwang; Toshihiro Horii
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

7.  Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note.

Authors:  Benjamin L Rice; Mónica M Acosta; Maria Andreína Pacheco; Ananias A Escalante
Journal:  Malar J       Date:  2013-08-21       Impact factor: 2.979

8.  Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences.

Authors:  Masanori Yagi; Gilles Bang; Takahiro Tougan; Nirianne M Q Palacpac; Nobuko Arisue; Taiki Aoshi; Yoshitsugu Matsumoto; Ken J Ishii; Thomas G Egwang; Pierre Druilhe; Toshihiro Horii
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

9.  An expanded global inventory of allelic variation in the most extremely polymorphic region of Plasmodium falciparum merozoite surface protein 1 provided by short read sequence data.

Authors:  Harvey Aspeling-Jones; David J Conway
Journal:  Malar J       Date:  2018-10-01       Impact factor: 2.979

Review 10.  Diversify and Conquer: The Vaccine Escapism of Plasmodium falciparum.

Authors:  Alena Pance
Journal:  Microorganisms       Date:  2020-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.